Investors in Kyverna Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTX
NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action